ProQR Therapeutics BV

Healthcare · Biotechnology

1.60$ +3.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

ProQR Therapeutics BV (PRQR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 133 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRQR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	73	66	58	48	46	64	52	44	138	110	114	103	81	132	114	105	129	121	108	193	226	210	212	187	119	183	172	161	150	152	134	127	119	174	164	161	146	113	114	133
Current Assets	69	62	55	45	43	61	49	41	136	108	110	98	78	129	111	102	108	98	86	170	205	191	192	168	102	165	154	143	132	134	116	109	103	159	149	146	131	100	100	122
Cash	65	59	52	42	40	58	47	38	132	106	106	94	75	126	108	98	104	93	80	165	181	188	186	164	98	101	151	140	128	131	93	85	100	155	143	141	126	92	93	117
Cash & Short-Term Investments	65	59	52	42	40	58	47	38	132	106	106	94	75	126	108	98	104	93	80	165	181	188	186	164	98	101	151	140	128	131	111	103	100	155	143	141	126	92	93	117
Receivables	0.5	0.4	0.4	0.7	0.8	0.5	1.2	1.2	1.4	1.2	1.7	1.6	0.8	1.3	1.1	0.5	0.6	0.5	0.5	0.5	0.6	0.6	0.9	0.5	0.6	61	0.5	0.4	3.4	1.4	3.4	4.9	1.5	2.1	3.0	2.8	3.0	5.1	3.1	1.9
Inventory	–	1.2	–	–	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	–	–	–	0.4	–	–	–	0.3	0.3	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–
Property, Plant & Equipment	4.1	3.6	3.4	3.4	3.2	3.0	2.8	2.6	2.4	3.2	3.9	3.5	2.4	2.4	2.3	2.1	18	19	18	18	18	17	17	17	17	16	–	16	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	11	12	12	12	13	17	16	17	19	18	23	23	22	27	24	16	49	52	50	53	78	96	100	96	56	112	108	105	101	107	96	91	91	82	79	83	79	63	71	54
Current Liabilities	7.8	6.7	6.6	5.5	6.4	10	8.7	10	12	8.2	11	10	11	12	10	10	13	13	12	15	40	28	26	28	26	22	19	25	28	38	37	40	44	40	36	39	39	32	40	35
Short-Term Debt	1.8	5.7	5.8	0.2	2.0	2.4	2.5	2.3	2.3	0.0	1.4	1.5	1.2	1.0	0.9	0.8	2.6	2.9	2.8	3.5	3.7	6.3	8.6	9.0	3.2	4.1	4.4	4.6	4.0	1.8	4.7	4.9	4.8	4.6	4.7	5.3	5.4	4.4	5.3	4.5
Accounts Payable	0.2	0.3	0.2	0.2	0.3	0.7	0.2	0.3	0.9	0.1	0.1	0.2	0.7	0.5	0.6	0.6	0.3	0.3	0.3	0.3	1.0	0.2	0.9	0.8	0.4	0.4	0.3	0.1	0.1	1.7	0.4	0.0	0.0	0.0	0.4	1.5	0.4	0.3	0.2	0.0
Long-Term Debt	4.1	6.0	4.9	6.9	7.7	6.4	7.0	7.0	7.3	16	10	10	11	13	13	4.9	17	16	17	17	18	39	38	38	4.8	4.3	3.9	3.6	2.9	4.3	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	61	53	46	37	33	47	36	27	119	93	91	80	60	106	90	90	80	70	58	140	149	114	112	91	64	72	64	57	49	46	38	35	28	92	85	79	67	49	43	79
Retained Earnings	-67	-76	-86	-98	-108	-143	-160	-160	-166	-155	-190	-206	-193	-238	-250	-260	-287	-315	-317	-338	-348	-318	-369	-362	-363	-405	-417	-428	-419	-443	-441	-440	-467	-442	-471	-526	-539	-467	-552	-487
Shares Outstanding	23	23	23	24	25	29	32	32	33	39	39	39	39	47	50	50	50	50	51	66	68	71	71	71	71	77	81	81	81	78	82	82	82	82	105	105	110	103	105	110

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings